These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12413360)

  • 41. [Adefovir dipivoxil is a new drug for treatment of chronic hepatitis B].
    Stránský J
    Vnitr Lek; 2004 Mar; 50(3):222-4. PubMed ID: 15125374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stick with tried-and-true breast cancer treatment.
    Health News; 2002 Jul; 8(7):5. PubMed ID: 12132502
    [No Abstract]   [Full Text] [Related]  

  • 43. New alternative to tamoxifen.
    Harv Womens Health Watch; 2002 Jul; 9(11):7. PubMed ID: 12138025
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
    Maratea D; Fadda V; Trippoli S; Messori A
    Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of adefovir and lamivudine combination therapy on lamivudine resistance chronic hepatitis B patients for 48 weeks].
    Xu QJ; Liang ZG; He ZK
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):540-1. PubMed ID: 20678449
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
    MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
    [No Abstract]   [Full Text] [Related]  

  • 47. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: what kind of evidence?].
    Angiolini C
    Suppl Tumori; 2004; 3(4):S75-6. PubMed ID: 15206219
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination therapy for chronic hepatitis B: a one-two knockout punch, or a swing and a miss?
    Chun S; Zucker SD
    Gastroenterology; 2006 Feb; 130(2):613-4; discussion 514-5. PubMed ID: 16472619
    [No Abstract]   [Full Text] [Related]  

  • 49. Femara approved as first-line breast cancer therapy.
    FDA Consum; 2001; 35(3):5. PubMed ID: 11458552
    [No Abstract]   [Full Text] [Related]  

  • 50. Adefovir for lamivudine resistant HBV: more than meets the eye.
    Di Marco V; Craxì A
    J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
    [No Abstract]   [Full Text] [Related]  

  • 51. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].
    Forciniti S
    Suppl Tumori; 2004; 3(4):S25-6. PubMed ID: 15206205
    [No Abstract]   [Full Text] [Related]  

  • 52. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
    Lampertico P
    J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
    [No Abstract]   [Full Text] [Related]  

  • 53. Future directions in endocrine treatment of advanced breast cancer.
    Bland KI
    Ann Surg Oncol; 1999 Dec; 6(8 Suppl):14S-16S. PubMed ID: 10619455
    [No Abstract]   [Full Text] [Related]  

  • 54. From the Food and Drug Administration.
    Schwetz BA
    JAMA; 2001 Mar; 285(9):1146. PubMed ID: 11231734
    [No Abstract]   [Full Text] [Related]  

  • 55. Spreading the word, but not too thinly.
    Howell A; Osborne CK; Mauriac L
    Lancet; 2004 Jan; 363(9403):165-6. PubMed ID: 14726176
    [No Abstract]   [Full Text] [Related]  

  • 56. New drugs 2016, part 2.
    Hussar DA
    Nursing; 2016 Jul; 46(7):26-33. PubMed ID: 27273173
    [No Abstract]   [Full Text] [Related]  

  • 57. New drugs. The class of 1991.
    Meyer C
    Am J Nurs; 1991 Dec; 91(12):40-3. PubMed ID: 1962681
    [No Abstract]   [Full Text] [Related]  

  • 58. From the Food and Drug Administration.
    McClellan MB
    JAMA; 2002 Nov; 288(17):2112. PubMed ID: 12413360
    [No Abstract]   [Full Text] [Related]  

  • 59. New treatment approved for chronic hepatitis B.
    FDA Consum; 2002; 36(6):4-5. PubMed ID: 12523284
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA notifications. New treatment approved for chronic hepatitis B.
    AIDS Alert; 2002 Nov; 17(11):146-7. PubMed ID: 12412570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.